Pyruvate metabolism disorder

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:254746
Who is this for?
Show terms as
21Specialists8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Pyruvate metabolism disorder (Orphanet code 254746) is a group classification encompassing a range of rare inherited metabolic conditions in which the body's ability to properly metabolize pyruvate is impaired. Pyruvate is a critical molecule at the crossroads of several metabolic pathways, including glycolysis, gluconeogenesis, and the citric acid (Krebs) cycle. Disorders of pyruvate metabolism include pyruvate dehydrogenase complex deficiency, pyruvate carboxylase deficiency, and phosphoenolpyruvate carboxykinase deficiency, among others. These conditions primarily affect the nervous system and energy-dependent organs such as the brain, muscles, heart, and liver, because impaired pyruvate metabolism leads to deficient cellular energy production and often to lactic acidosis. Key clinical features vary depending on the specific enzyme affected but commonly include lactic acidosis, developmental delay, intellectual disability, seizures, hypotonia (low muscle tone), failure to thrive, and progressive neurological deterioration. Some patients may present with structural brain abnormalities, movement disorders, or episodes of metabolic crisis triggered by illness or fasting. Onset is typically in the neonatal or infantile period, though milder forms may present later in childhood. Treatment is largely supportive and depends on the specific underlying enzyme deficiency. Dietary interventions such as a ketogenic diet have shown benefit in some forms, particularly pyruvate dehydrogenase complex deficiency, by providing an alternative energy source (ketone bodies) that bypasses the metabolic block. Thiamine supplementation may be helpful in thiamine-responsive cases. Cofactor supplementation, avoidance of fasting, and management of acute metabolic crises with bicarbonate and glucose are also part of the therapeutic approach. Despite treatment, prognosis remains guarded for many patients, particularly those with severe neonatal presentations.

Inheritance

Variable

Can be inherited in different ways depending on the underlying gene

Age of Onset

Variable

Can begin at different ages, from infancy through adulthood

Orphanet ↗NORD ↗

FDA & Trial Timeline

5 events
Oct 2024Hyperpolarized MR Imaging with Carbon-13 Pyruvate in the Human Body

National Heart Centre Singapore — PHASE2

TrialRECRUITING
Oct 2023Hyperpolarized 13C-pyruvate Metabolic MRI With Traumatic Brain Injury

University of Maryland, Baltimore — PHASE1

TrialRECRUITING
Dec 2020Utility of Hyperpolarized 13C-pyruvate Metabolic Magnetic Resonance Imaging

University of Maryland, Baltimore — PHASE2

TrialRECRUITING
Jun 2018Imaging of Traumatic Brain Injury Metabolism Using Hyperpolarized Carbon-13 Pyruvate

University of Texas Southwestern Medical Center — EARLY_PHASE1

TrialENROLLING BY INVITATION
Apr 2016Metabolic Imaging of the Heart Using Hyperpolarized (13C) Pyruvate Injection

Sunnybrook Health Sciences Centre — PHASE1

TrialRECRUITING

Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Treatments

No FDA-approved treatments are currently listed for Pyruvate metabolism disorder.

View clinical trials →

No actively recruiting trials found for Pyruvate metabolism disorder at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Pyruvate metabolism disorder community →

Specialists

21 foundView all specialists →
BM
Bruce Cohen, MD
Specialist
PI on 1 active trial
JP
Jirair Bedoyan, MD, PhD
PITTSBURGH, PA
Specialist
PI on 1 active trial
IM
Irene Litvan, MD
LOUISVILLE, KY
Specialist
PI on 1 active trial1 Pyruvate metabolism disorder publication
MM
Mary Kay Koenig, MD
Houston, Texas
Specialist

Rare Disease Specialist

PI on 4 active trials
MM
Michio Hirano, MD
NEW YORK, NY
Specialist
PI on 10 active trials
RM
Richard Neibeger, MD
Orange, California
Specialist

Rare Disease Specialist

PI on 1 active trial
VM
Vinay Penematsa, MD
Specialist
PI on 4 active trials
TD
Thomas Klopstock, Prof. Dr.
Specialist
PI on 3 active trials
MD
Michelangelo Mancuso, Prof. Dr.
Specialist
PI on 1 active trial
KM
Kitt F Petersen, MD
Specialist
PI on 1 active trial
ZM
Zhen Jane Wang, MD
Specialist
PI on 1 active trial
CP
Charles Cunningham, PhD
Specialist
PI on 1 active trial
DN
Dirk Mayer, Dr. rer. nat.
Specialist
PI on 1 active trial
JP
Jirair K. Bedoyan, MD, PhD
PITTSBURGH, PA
Specialist
PI on 1 active trial
VP
Vlad G Zaha, MD, PhD
DALLAS, TX
Specialist
PI on 2 active trials
LM
Leticia Castillo, MD
Specialist
PI on 1 active trial1 Pyruvate metabolism disorder publication

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Pyruvate metabolism disorder.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Pyruvate metabolism disorderForum →

No community posts yet. Be the first to share your experience with Pyruvate metabolism disorder.

Start the conversation →

Latest news about Pyruvate metabolism disorder

Disease timeline:

New recruiting trial: Utility of Hyperpolarized 13C-pyruvate Metabolic Magnetic Resonance Imaging

A new clinical trial is recruiting patients for Pyruvate metabolism disorder

New recruiting trial: Metabolic Imaging of the Heart Using Hyperpolarized (13C) Pyruvate Injection

A new clinical trial is recruiting patients for Pyruvate metabolism disorder

New recruiting trial: Hyperpolarized MR Imaging with Carbon-13 Pyruvate in the Human Body

A new clinical trial is recruiting patients for Pyruvate metabolism disorder

New recruiting trial: Hyperpolarized 13C-pyruvate Metabolic MRI With Traumatic Brain Injury

A new clinical trial is recruiting patients for Pyruvate metabolism disorder

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Pyruvate metabolism disorder

What is Pyruvate metabolism disorder?

Pyruvate metabolism disorder (Orphanet code 254746) is a group classification encompassing a range of rare inherited metabolic conditions in which the body's ability to properly metabolize pyruvate is impaired. Pyruvate is a critical molecule at the crossroads of several metabolic pathways, including glycolysis, gluconeogenesis, and the citric acid (Krebs) cycle. Disorders of pyruvate metabolism include pyruvate dehydrogenase complex deficiency, pyruvate carboxylase deficiency, and phosphoenolpyruvate carboxykinase deficiency, among others. These conditions primarily affect the nervous system

Which specialists treat Pyruvate metabolism disorder?

21 specialists and care centers treating Pyruvate metabolism disorder are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.